SEC Tracker
Get the app

Aktis Oncology AKTS

Aktis Oncology Reports Financial Results and Business Highlights For First Quarter 2026

Form
8-K
Filed
Importance
Major
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Aktis Oncology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. 4D Molecular Therapeutics FDMT public float $166M, Jun 30, 2025
  2. Charlie's Holdings CHUC public float $18M, Jun 30, 2025
  3. CV Sciences CVSI public float $7M, Jun 30, 2025
  4. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025
  5. Voyager Therapeutics VYGR public float $144M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.